Stefan Vonhoff, PhDVice President CMC at NOXXON Pharma AG
Profile
Stefan Vonhoff, Ph.D. is VP Chemistry&Manufacturing at NOXXON Pharma AG, Berlin, Germany, a biotech company developing Spiegelmers – enantiomeric aptamers – for various therapeutic indications in the oncology area. Stefan joined NOXXON in 1999 to support supply chain establishment for this novel class of oligonucleotide therapeutics. Today, his main responsibility is to coordinate external manufacturing and QC/QP-release activities for starting materials, drug substance, parenteral drug product and clinical trial supply.
Agenda Sessions
Drug Product Development Strategies for Oligonucleotides and Peptides
11:15View Session“Points-to-Consider” When Planning Your First Oligonucleotide Drug Product Campaign
On DemandView Session“Points-to-Consider” When Planning Your First Oligonucleotide Drug Product Campaign
On DemandView Session